OCBV
Ownership Capital B.V. Portfolio holdings
AUM
$1.72B
This Quarter Return
+1.6%
1 Year Return
+10.9%
3 Year Return
+59.02%
5 Year Return
+61.6%
10 Year Return
+352.96%
AUM
$8.83B
AUM Growth
+$8.83B
(+2.7%)
Cap. Flow
+$210M
Cap. Flow
% of AUM
2.38%
Top 10 Holdings %
Top 10 Hldgs %
59.34%
Holding
24
New
1
Increased
17
Reduced
6
Closed
–
Top Buys
| 1 |
Synopsys
SNPS
|
$217M |
| 2 |
DexCom
DXCM
|
$101M |
| 3 |
Tyler Technologies
TYL
|
$43M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
$39.1M |
| 5 |
Intuit
INTU
|
$19.6M |
Top Sells
| 1 |
Boston Scientific
BSX
|
$136M |
| 2 |
Intercontinental Exchange
ICE
|
$77.3M |
| 3 |
Verisk Analytics
VRSK
|
$53.7M |
| 4 |
Mastercard
MA
|
$50.9M |
| 5 |
Bio-Techne
TECH
|
$39.2M |
Sector Composition
| 1 | Healthcare | 36.26% |
| 2 | Technology | 29.76% |
| 3 | Financials | 26.57% |
| 4 | Industrials | 3.85% |
| 5 | Real Estate | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Intuit
INTU
$186B
| $621M | 7.04% | 1,151,758 +36,413 | +3% | +$19.6M |
|
|
2
Mastercard
MA
$538B
| $599M | 6.78% | 1,721,425 -146,417 | -8% | -$50.9M |
|
3
Edwards Lifesciences
EW
$47.8B
| $574M | 6.5% | 5,066,576 +160,960 | +3% | +$18.2M |
|
4
Masimo
MASI
$7.59B
| $544M | 6.17% | 2,010,906 +71,861 | +4% | +$19.5M |
|
5
MarketAxess Holdings
MKTX
$6.87B
| $520M | 5.9% | 1,237,192 -70,486 | -5% | -$29.7M |
|
|
ANSS
6
DELISTED
Ansys
ANSS
| $497M | 5.63% | 1,461,047 +46,252 | +3% | +$15.7M |
|
|
7
Bio-Techne
TECH
$8.5B
| $487M | 5.52% | 1,005,277 -80,854 | -7% | -$39.2M |
|
8
Tradeweb Markets
TW
$26.3B
| $482M | 5.46% | 5,965,276 +218,668 | +4% | +$17.7M |
|
9
Workday
WDAY
$61.6B
| $459M | 5.2% | 1,838,381 +58,031 | +3% | +$14.5M |
|
10
PayPal
PYPL
$67.1B
| $454M | 5.15% | 1,746,044 +64,851 | +4% | +$16.9M |
|
11
Illumina
ILMN
$15.8B
| $431M | 4.89% | 1,063,540 +39,649 | +4% | +$16.1M |
|
|
12
Tyler Technologies
TYL
$24.4B
| $422M | 4.78% | 919,389 +93,792 | +11% | +$43M |
|
13
PTC
PTC
$25.6B
| $376M | 4.26% | 3,136,552 +99,373 | +3% | +$11.9M |
|
14
ResMed
RMD
$40.2B
| $365M | 4.14% | 1,385,409 +44,070 | +3% | +$11.6M |
|
|
15
Verisk Analytics
VRSK
$37.5B
| $340M | 3.85% | 1,696,151 -268,322 | -14% | -$53.7M |
|
16
CoStar Group
CSGP
$37.9B
| $313M | 3.55% | 3,641,272 +115,692 | +3% | +$9.96M |
|
|
17
Intercontinental Exchange
ICE
$101B
| $291M | 3.3% | 2,533,594 -673,440 | -21% | -$77.3M |
|
|
ABMD
18
DELISTED
Abiomed Inc
ABMD
| $236M | 2.67% | 724,443 +120,266 | +20% | +$39.1M |
|
|
19
Synopsys
SNPS
$112B
| $217M | 2.46% | +724,778 | New | +$217M |
|
|
20
DexCom
DXCM
$29.5B
| $168M | 1.9% | 307,395 +185,367 | +152% | +$101M |
|
21
Maravai LifeSciences
MRVI
$350M
| $133M | 1.51% | 2,717,559 +388,755 | +17% | +$19.1M |
|
22
Mettler-Toledo International
MTD
$26.8B
| $132M | 1.49% | 95,673 +3,027 | +3% | +$4.17M |
|
|
23
Boston Scientific
BSX
$156B
| $131M | 1.48% | 3,017,139 -3,128,779 | -51% | -$136M |
|
24
AppFolio
APPF
$9.94B
| $35.2M | 0.4% | 292,212 +9,271 | +3% | +$1.12M |
|